|
Volumn 4, Issue 1, 2006, Pages 58-60
|
Pipeline
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
APTAMER;
BENZOPORPHYRIN DERIVATIVE;
BEVACIZUMAB;
CHLORINATED HYDROCARBON;
CYANOACRYLATE;
CYCLOOXYGENASE 2 INHIBITOR;
DRINKING WATER;
FIBRIN GLUE;
FLUOROURACIL;
FOSSIL FUEL;
MITOMYCIN C;
NON PRESCRIPTION DRUG;
PEGAPTANIB;
PENICILLIN G;
PHOTOSENSITIZING AGENT;
RANIBIZUMAB;
VASCULOTROPIN ANTIBODY;
IMMUNOSUPPRESSIVE AGENT;
ARTHRITIS;
CARDIOVASCULAR DISEASE;
CHLORINATION;
CLINICAL TRIAL;
CORNEA DISEASE;
DRUG APPROVAL;
DRUG INDICATION;
EDITORIAL;
GASTROINTESTINAL TOXICITY;
GREENHOUSE EFFECT;
HUMAN;
NUCLEAR ENERGY;
PRESCRIPTION;
RETINA MACULA AGE RELATED DEGENERATION;
RISK BENEFIT ANALYSIS;
SUBRETINAL NEOVASCULARIZATION;
ARTICLE;
DECISION MAKING;
ORGANIZATION;
RETINA MACULA DEGENERATION;
RISK FACTOR;
TREATMENT OUTCOME;
UNITED STATES;
CONGRESSES;
DECISION MAKING;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MACULAR DEGENERATION;
RISK FACTORS;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 33344477046
PISSN: 15420124
EISSN: 15420124
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (4)
|
References (5)
|